Author:
Panda Pankaj Kumar,Tan Daniel Shao-Weng
Reference39 articles.
1. Avelumab, an anti-programmed death-ligand 1 antibody, in patients with refractory metastatic urothelial carcinoma: Results from a multicenter, phase Ib study;Apolo;Journal of Clinical Oncology,2017
2. Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt;Bedwani;British Journal of Cancer,1998
3. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: Association of NAT1∗10 allele with higher N-acetylation activity in bladder and colon tissue;Bell;Cancer Research,1995
4. Trends in cancer mortality in the Americas, 1970–2000;Bosetti;Annals of Oncology,2005
5. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline;Chang;The Journal of Urology,2016